GSK Investigational Site

Durham, North Carolina 27705

Use our guide to learn which trials are right for you!

We've found
10 trials
at this facility
Overweight Clinical Trial
Orlistat Body Composition Study
Status: Enrolling
Updated: 9/18/2008
mi
from
Durham, NC
Click here to add this to my saved trials
Adenomyosis Clinical Trial
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling, Phase II
Updated: 8/16/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Asthma Clinical Trial
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
Status: Enrolling, Phase III
Updated: 1/12/2018
mi
from
Durham, NC
Click here to add this to my saved trials
Obstetric Labour, Premature Clinical Trial
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Infections, Meningococcal Clinical Trial
GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Neoplasms Clinical Trial
Pilot Immunotherapy With Autologous T-cells Specific for New York Esophageal Antigen-1 (NY-ESO-1)/ Cancer-testis Antigen-2 (LAGE-1a)-Positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Infection, Human Immunodeficiency Virus Clinical Trial
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV
Status: Enrolling, Phase
Updated: 3/5/2018
mi
from
Durham, NC
Click here to add this to my saved trials